Atea Pharmaceuticals Stock Volatility

AVIR -  USA Stock  

USD 24.74  0.37  1.47%

Atea Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0506, which signifies that the company had -0.0506% of return per unit of standard deviation over the last 3 months. Macroaxis philosophy in foreseeing the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Atea Pharmaceuticals exposes twenty-eight different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm Atea Pharmaceuticals risk adjusted performance of (0.06), and Mean Deviation of 4.17 to double-check the risk estimate we provide.

Search Volatility 

 
Refresh
Atea Pharmaceuticals Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Atea Pharmaceuticals daily returns, and it is calculated using variance and standard deviation. We also use Atea Pharmaceuticals's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Atea Pharmaceuticals volatility.

90 Days Market Risk

Not too volatile

Chance of Distress

High

90 Days Economic Sensitivity

Barely shadows the market

Atea Pharmaceuticals Market Sensitivity And Downside Risk

Atea Pharmaceuticals' beta coefficient measures the volatility of Atea Pharmaceuticals stock compared to the systematic risk of the entire stock market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Atea Pharmaceuticals stock's returns against your selected market. In other words, Atea Pharmaceuticals's beta of 0.0455 provides an investor with an approximation of how much risk Atea Pharmaceuticals stock can potentially add to one of your existing portfolios.
Let's try to break down what Atea Pharmaceuticals's beta means in this case. As returns on the market increase, Atea Pharmaceuticals returns are expected to increase less than the market. However, during the bear market, the loss on holding Atea Pharmaceuticals will be expected to be smaller as well.
3 Months Beta |Analyze Atea Pharmaceuticals Demand Trend
Check current 90 days Atea Pharmaceuticals correlation with market (DOW)

Atea Pharmaceuticals Beta

    
  0.0455  
Atea Pharmaceuticals standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. Typical volatile equity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

    
  5.79  
It is essential to understand the difference between upside risk (as represented by Atea Pharmaceuticals's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Atea Pharmaceuticals stock's daily returns or price. Since the actual investment returns on holding a position in Atea Pharmaceuticals stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Atea Pharmaceuticals.

Atea Pharmaceuticals Stock Volatility Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Atea Pharmaceuticals Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input. View also all equity analysis or get more info about average price price transform indicator.

Atea Pharmaceuticals Projected Return Density Against Market

Given the investment horizon of 90 days Atea Pharmaceuticals has a beta of 0.0455 . This suggests as returns on the market go up, Atea Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Atea Pharmaceuticals will be expected to be much smaller as well.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Atea Pharmaceuticals or Pharmaceutical Products sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Atea Pharmaceuticals stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Atea Pharmaceuticals stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
The company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Atea Pharmaceuticals is significantly underperforming DOW.
 Predicted Return Density 
      Returns 

Atea Pharmaceuticals Stock Risk Measures

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Atea Pharmaceuticals or Pharmaceutical Products sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Atea Pharmaceuticals stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Atea Pharmaceuticals stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Given the investment horizon of 90 days the coefficient of variation of Atea Pharmaceuticals is -1974.37. The daily returns are distributed with a variance of 33.57 and standard deviation of 5.79. The mean deviation of Atea Pharmaceuticals is currently at 4.06. For similar time horizon, the selected benchmark (DOW) has volatility of 0.75
α
Alpha over DOW
-0.57
β
Beta against DOW0.0455
σ
Overall volatility
5.79
Ir
Information ratio -0.1

Atea Pharmaceuticals Stock Return Volatility

Atea Pharmaceuticals historical daily return volatility represents how much Atea Pharmaceuticals stock's price daily returns swing around its mean daily price change - it is a statistical measure of its dispersion of returns. The enterprise inherits 5.7941% risk (volatility on return distribution) over the 90 days horizon. By contrast, DOW inherits 0.7437% risk (volatility on return distribution) over the 90 days horizon.
 Performance (%) 
      Timeline 

About Atea Pharmaceuticals Volatility

Volatility is a rate at which the price of Atea Pharmaceuticals or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Atea Pharmaceuticals may increase or decrease. In other words, similar to Atea Pharmaceuticals's beta indicator, it measures the risk of Atea Pharmaceuticals and helps estimate the fluctuations that may happen in a short period of time. So if prices of Atea Pharmaceuticals fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
Last ReportedProjected for 2021
Market Capitalization3.1 B3.1 B
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts. Atea Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs people.

Atea Pharmaceuticals Investment Opportunity

Atea Pharmaceuticals has a volatility of 5.79 and is 7.82 times more volatile than DOW. 49  of all equities and portfolios are less risky than Atea Pharmaceuticals. Compared to the overall equity markets, volatility of historical daily returns of Atea Pharmaceuticals is lower than 49 () of all global equities and portfolios over the last 90 days. Use Atea Pharmaceuticals to protect your portfolios against small market fluctuations. The stock experiences a somewhat bearish sentiment, but the market may correct it shortly. Check odds of Atea Pharmaceuticals to be traded at $24.0 in 90 days. . Let's try to break down what Atea Pharmaceuticals's beta means in this case. As returns on the market increase, Atea Pharmaceuticals returns are expected to increase less than the market. However, during the bear market, the loss on holding Atea Pharmaceuticals will be expected to be smaller as well.

Significant diversification

The correlation between Atea Pharmaceuticals and DJI is Significant diversification for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Atea Pharmaceuticals and DJI in the same portfolio assuming nothing else is changed.

Atea Pharmaceuticals Additional Risk Indicators

The analysis of Atea Pharmaceuticals' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Atea Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some common measures of Atea Pharmaceuticals stock risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Risk Adjusted Performance(0.06)
Market Risk Adjusted Performance(12.52)
Mean Deviation4.17
Coefficient Of Variation(1,040)
Standard Deviation5.82
Variance33.91
Information Ratio(0.10)
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stock investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Atea Pharmaceuticals Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
Salesforce vs. Atea Pharmaceuticals
Blackrock vs. Atea Pharmaceuticals
Ford vs. Atea Pharmaceuticals
Cf Industries vs. Atea Pharmaceuticals
Otp Bank vs. Atea Pharmaceuticals
Ashland Global vs. Atea Pharmaceuticals
Aquestive Therapeutics vs. Atea Pharmaceuticals
Vmware vs. Atea Pharmaceuticals
Abiomed vs. Atea Pharmaceuticals
Sentinelone Inc vs. Atea Pharmaceuticals
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Atea Pharmaceuticals as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Atea Pharmaceuticals' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Atea Pharmaceuticals' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Atea Pharmaceuticals.
Please continue to Trending Equities. Note that the Atea Pharmaceuticals information on this page should be used as a complementary analysis to other Atea Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Complementary Tools for Atea Pharmaceuticals Stock analysis

When running Atea Pharmaceuticals price analysis, check to measure Atea Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea Pharmaceuticals is operating at the current time. Most of Atea Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Atea Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Atea Pharmaceuticals' price. Additionally, you may evaluate how the addition of Atea Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
The market value of Atea Pharmaceuticals is measured differently than its book value, which is the value of Atea Pharmaceuticals that is recorded on the company's balance sheet. Investors also form their own opinion of Atea Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Atea Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atea Pharmaceuticals' market value can be influenced by many factors that don't directly affect Atea Pharmaceuticals underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atea Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Atea Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atea Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.